441 related articles for article (PubMed ID: 18281485)
21. Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer.
Yang H; Kim C; Kim MJ; Schwendener RA; Alitalo K; Heston W; Kim I; Kim WJ; Koh GY
Mol Cancer; 2011 Apr; 10():36. PubMed ID: 21481239
[TBL] [Abstract][Full Text] [Related]
22. Lymphangiogenesis in chronic inflammation in the testis.
Hirai S; Naito M; Terayama H; Qu N; Kuerban M; Musha M; Itoh M
Andrology; 2013 Jan; 1(1):147-54. PubMed ID: 23258644
[TBL] [Abstract][Full Text] [Related]
23. Lymphangiogenesis in aortic valve stenosis--novel regulatory roles for valvular myofibroblasts and mast cells.
Syväranta S; Helske S; Lappalainen J; Kupari M; Kovanen PT
Atherosclerosis; 2012 Apr; 221(2):366-74. PubMed ID: 22281299
[TBL] [Abstract][Full Text] [Related]
24. Soluble FLT-1 expression suppresses carcinomatous ascites in nude mice bearing ovarian cancer.
Hasumi Y; Mizukami H; Urabe M; Kohno T; Takeuchi K; Kume A; Momoeda M; Yoshikawa H; Tsuruo T; Shibuya M; Taketani Y; Ozawa K
Cancer Res; 2002 Apr; 62(7):2019-23. PubMed ID: 11929819
[TBL] [Abstract][Full Text] [Related]
25. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
[TBL] [Abstract][Full Text] [Related]
26. Role of lymphangiogenesis and lymphangiogenic factors during pancreatic cancer progression and lymphatic spread.
Schneider M; Büchler P; Giese N; Giese T; Wilting J; Büchler MW; Friess H
Int J Oncol; 2006 Apr; 28(4):883-90. PubMed ID: 16525637
[TBL] [Abstract][Full Text] [Related]
27. Pathogenesis of ascites tumor growth: angiogenesis, vascular remodeling, and stroma formation in the peritoneal lining.
Nagy JA; Morgan ES; Herzberg KT; Manseau EJ; Dvorak AM; Dvorak HF
Cancer Res; 1995 Jan; 55(2):376-85. PubMed ID: 7529135
[TBL] [Abstract][Full Text] [Related]
28. Tumour expression of lymphangiogenic growth factors but not lymphatic vessel density is implicated in human cervical cancer progression.
Sotiropoulou N; Bravou V; Kounelis S; Damaskou V; Papaspirou E; Papadaki H
Pathology; 2010 Dec; 42(7):629-36. PubMed ID: 21080871
[TBL] [Abstract][Full Text] [Related]
29. Vascular endothelial growth factor D is dispensable for development of the lymphatic system.
Baldwin ME; Halford MM; Roufail S; Williams RA; Hibbs ML; Grail D; Kubo H; Stacker SA; Achen MG
Mol Cell Biol; 2005 Mar; 25(6):2441-9. PubMed ID: 15743836
[TBL] [Abstract][Full Text] [Related]
30. LYVE-1-positive macrophages are present in normal murine eyes.
Xu H; Chen M; Reid DM; Forrester JV
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2162-71. PubMed ID: 17460275
[TBL] [Abstract][Full Text] [Related]
31. Expression of VEGFR-3 and 5'-nase in regenerating lymphatic vessels of the cutaneous wound healing.
Ji RC; Miura M; Qu P; Kato S
Microsc Res Tech; 2004 Jun; 64(3):279-86. PubMed ID: 15452895
[TBL] [Abstract][Full Text] [Related]
32. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
[TBL] [Abstract][Full Text] [Related]
33. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice.
Veikkola T; Jussila L; Makinen T; Karpanen T; Jeltsch M; Petrova TV; Kubo H; Thurston G; McDonald DM; Achen MG; Stacker SA; Alitalo K
EMBO J; 2001 Mar; 20(6):1223-31. PubMed ID: 11250889
[TBL] [Abstract][Full Text] [Related]
34. Spreds are essential for embryonic lymphangiogenesis by regulating vascular endothelial growth factor receptor 3 signaling.
Taniguchi K; Kohno R; Ayada T; Kato R; Ichiyama K; Morisada T; Oike Y; Yonemitsu Y; Maehara Y; Yoshimura A
Mol Cell Biol; 2007 Jun; 27(12):4541-50. PubMed ID: 17438136
[TBL] [Abstract][Full Text] [Related]
35. Erythropoietin induces lymph node lymphangiogenesis and lymph node tumor metastasis.
Lee AS; Kim DH; Lee JE; Jung YJ; Kang KP; Lee S; Park SK; Kwak JY; Lee SY; Lim ST; Sung MJ; Yoon SR; Kim W
Cancer Res; 2011 Jul; 71(13):4506-17. PubMed ID: 21586615
[TBL] [Abstract][Full Text] [Related]
36. Endothelin-1 stimulates lymphatic endothelial cells and lymphatic vessels to grow and invade.
Spinella F; Garrafa E; Di Castro V; Rosanò L; Nicotra MR; Caruso A; Natali PG; Bagnato A
Cancer Res; 2009 Mar; 69(6):2669-76. PubMed ID: 19276384
[TBL] [Abstract][Full Text] [Related]
37. Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability.
Cao R; Eriksson A; Kubo H; Alitalo K; Cao Y; Thyberg J
Circ Res; 2004 Mar; 94(5):664-70. PubMed ID: 14739162
[TBL] [Abstract][Full Text] [Related]
38. Remodeling of the lymphatic vasculature during mouse mammary gland morphogenesis is mediated via epithelial-derived lymphangiogenic stimuli.
Betterman KL; Paquet-Fifield S; Asselin-Labat ML; Visvader JE; Butler LM; Stacker SA; Achen MG; Harvey NL
Am J Pathol; 2012 Dec; 181(6):2225-38. PubMed ID: 23063660
[TBL] [Abstract][Full Text] [Related]
39. Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts.
Nykänen AI; Sandelin H; Krebs R; Keränen MA; Tuuminen R; Kärpänen T; Wu Y; Pytowski B; Koskinen PK; Ylä-Herttuala S; Alitalo K; Lemström KB
Circulation; 2010 Mar; 121(12):1413-22. PubMed ID: 20231530
[TBL] [Abstract][Full Text] [Related]
40. [Expression of vascular endothelial growth factors (VEGF)-A, -C and -D and their prognostic significance and relationship with angio- and lymphangiogenesis in gastric cancer].
Wang XL; Ai ZS; Fang JP; Tang RY; Chen XM
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):837-43. PubMed ID: 19173829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]